Multiplex Assay Kit for Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay)

PLC; PRCAN; SJA; SJS; SJS1; Perlecan; Endorepellin; Schwartz-Jampel Syndrome 1; Basement membrane-specific heparan sulfate proteoglycan core protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-101 94
EDTA plasma(n=5) 82-90 86
heparin plasma(n=5) 85-104 95
sodium citrate plasma(n=5) 81-90 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-97% 87-99% 98-105% 80-95%
EDTA plasma(n=5) 82-90% 97-104% 80-105% 93-101%
heparin plasma(n=5) 99-105% 94-105% 78-97% 93-101%
sodium citrate plasma(n=5) 79-94% 82-101% 94-104% 85-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:HSPG2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
European journal of pharmacology Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme Pubmed: 24530413
The Journal of Clinical Endocrinology &amp; Metabolism Proteomics of Follicular Fluid From Women With Polycystic Ovary Syndrome Suggests Molecular Defects in Follicular Development Pubmed:25393639
Am J Transplant. Key Matrix Proteins Within the Pancreatic Islet Basement Membrane Are Differentially Digested During Human Islet Isolation. pubmed:27456745
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA Expression and Circulating Levels of Perlecan in Breast Cancer-Implications for Oestrogen Dependent Stromal Remodeling Pubmed: 32124140
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC748Hu01 Recombinant Heparan Sulfate Proteoglycan 2 (HSPG2) Positive Control; Immunogen; SDS-PAGE; WB.
PAC748Hu01 Polyclonal Antibody to Heparan Sulfate Proteoglycan 2 (HSPG2) WB,IHC,ICC/IF
LAC748Hu71 Biotin-Linked Polyclonal Antibody to Heparan Sulfate Proteoglycan 2 (HSPG2) WB; IHC; ICC.
MAC748Hu22 Monoclonal Antibody to Heparan Sulfate Proteoglycan 2 (HSPG2) WB; IHC; ICC; IP.
SEC748Hu ELISA Kit for Heparan Sulfate Proteoglycan 2 (HSPG2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC748Hu Multiplex Assay Kit for Heparan Sulfate Proteoglycan 2 (HSPG2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.